Through DPL’s online platforms, cardholders can stream or download e-books, audiobooks, magazines and even comics. The ...

Johnson & Johnson’s medical technology unit and its health data company Verily have penned separate new deals with technology ...

The unveiling of the second prototype of China’s J-36 stealth fighter has revealed significant structural changes, ...

J&J will now explore Rybrevant's efficacy and safety in a Phase III trial in first-line, EGFR-driven HNSCC and colorectal ...

Assistant Professor of Information Technology Management Mahesh Boodraj had his paper, “ Beyond Passwords: A Review of the ...

Eli Lilly and Johnson & Johnson are joining fellow Big Pharma peers in upping their investment in AI, with Lilly looking to ...

At least nine people were injured, including juveniles, early Sunday when gunfire erupted at a large birthday party at an ...

Six of the new stores have already opened at the huge mall in Paramus, with one more slated to debut later this fall, ...

REESTABLISHING AMERICAN LEADERSHIP: President Trump’s State Visit to Korea reaffirmed the steadfast alliance between the United States and the ROK, while advancing U.S. economic interests—delivering ...

Forests have been benefiting humanity since long before the health benefits of forest bathing were discovered. They are major ...

AM Best reduced the financial strength rating of the property casualty members of Erie Indemnity (NASDAQ:ERIE) Insurance ...

UroGen Pharma shows strong growth with RTGel technology, FDA approvals for JELMYTO and ZUSDURI, and accelerating 2026 revenue outlook. See why URGN stock is a buy.